THE DEAL, AT A GLANCE
From the announcementInovalon
01What it doesThe new capital is framed around Build Inovalon AI clinical intelligence and expand to pharmaceutical analytics.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Nordic CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedInovalon raised $1B Growth RoundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersInovalon is using Growth Round capital to extend an AI cloud platform for healthcare data analytics from clinical intelligence into pharmaceutical analytics.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Inovalon · Financing Record
Explore source-linked visual explanations for Inovalon. Unsupported claims are withheld while source review continues.
Record 1612 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →